Clinical Trials for Reviva Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Reviva Pharmaceuticals

Clinical Trials (1)

NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
PHASE3Recruiting
690 participants
Started: Jan 24, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor18 locations